Search Results for: Special Investigations Unit

Staying Ahead of the Surge in Medicare Revocation Actions - Featured Image - Liles Parker

Fraud Risks Facing Recovery Residences: A Guide for Owners & Managers

(June 1, 2026): Recovery residences[1] (sometimes referred to as sober homes) play a significant role in supporting individuals with substance use disorders who need stable, supportive housing. But the same features that make recovery residences important to the continuum of care also create substantial legal exposure for owners, operators, investors, and managers. These risks do

Fraud Risks Facing Recovery Residences: A Guide for Owners & Managers Read More »

Staying Ahead of the Surge in Medicare Revocation Actions - Featured Image - Liles Parker

Staying Ahead of the Surge in Medicare Revocation Actions

(April 13, 2026): Physicians, home health agencies, and hospices constantly strive to ensure the well-being of their patients. Unfortunately, over the past few years, scores of providers have found themselves at odds with the Centers for Medicare & Medicaid Services (CMS) and its contractors. If you think “It Can’t Happen to Me,” consider this –

Staying Ahead of the Surge in Medicare Revocation Actions Read More »

Delta Dental Audits Will Increase in 2026. Is Your Practice Ready? - Featured Image - Liles Parker

Delta Dental Audits Will Increase in 2026. Is Your Practice Ready?

(January 13, 2026): As the great Yogi Berra once said, “It’s tough to make predictions – especially about the future.” This maxim is especially true when it comes to forecasting the specific dental claim risk issues that will be the focus of private payor Special Investigation Units (SIUs) in 2026. Nevertheless, we are going to

Delta Dental Audits Will Increase in 2026. Is Your Practice Ready? Read More »

Responding to Medicare Audits of PCR Testing for UTIs in 2026 - Liles Parker

Responding to Medicare Audits of PCR Testing for UTIs in 2026

(December 18, 2025): Laboratory Polymerase Chain Reaction (PCR) testing for urinary tract infections (UTIs) offers rapid, sensitive pathogen detection but often presents complex coding and billing challenges for Medicare providers and laboratories. Medicare contractors are increasingly denying UTI test claims due to issues with medical necessity, documentation, and improper coding/billing practices. Robust compliance and up-to-date

Responding to Medicare Audits of PCR Testing for UTIs in 2026 Read More »

Wound care aukdit and skin substitute audit 2026 - Featured Image - Liles Parker

Responding to Wound Care Audits and Skin Substitute Audits in 2026

CMS UPDATE – DECEMBER 24, 2025 “Effective immediately, CMS’ A/B Medicare Administrative Contractors (MACs) are withdrawing the Local Coverage Determinations (LCDs) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers that were scheduled to become effective on January 1, 2026.” ORIGINAL ARTICLE (December 11, 2025): In 1789,

Responding to Wound Care Audits and Skin Substitute Audits in 2026 Read More »

Michael Tobin 235x250 - Attorney - Liles Parker

Michael Tobin, J.D., C.P.C., B.S.

Associate Attorney Office: (202) 298-8750 Practice Concentration and Experience: Michael Tobin practices in the area of health care regulatory compliance. Mr. Tobin has experience with auditing claims, Anti-Kickback Statute, and False Claims Act issues. Mr. Tobin also assists providers with identifying deficiencies, improving their documentation, and creating and implementing effective compliance plans. Mr. Tobin attended

Michael Tobin, J.D., C.P.C., B.S. Read More »

Audits of Semaglutide and Other GLP-1 Claims are Increasing

Prescriber Risks Ordering Semaglutide, Tirzepatide and Other Compounded GLP-1 Medications

(October 24, 2024): Semaglutide, tirzepatide and a slate of other GLP-1 receptor agonist medications have dominated weight loss headlines in recent years. Not surprisingly, many weight loss providers and clinics have refocused their approaches, incorporating these drugs into patient treatment regimens. Unfortunately, the popularity of these drugs has led to a variety of bad practices,

Prescriber Risks Ordering Semaglutide, Tirzepatide and Other Compounded GLP-1 Medications Read More »

The OPM Debarment Action on Health care Providers - Liles Parker - Dec 2023

The OPM Debarment Process – Responding to an FEHBP Debarment or Suspension Action in 2024

(December 20, 2023): Most health care providers and suppliers are familiar with the fact that as a participating provider in the Medicare and / or Medicaid programs, certain criminal convictions, adverse licensure actions, and various types of prohibited conduct may subject the provider to exclusion from participation in Federal health care programs[1] by the Department

The OPM Debarment Process – Responding to an FEHBP Debarment or Suspension Action in 2024 Read More »

Hospice Audit and Investigative Actions are Expected to Rise in 2024 - November 2023

Hospice Audit and Investigative Actions are Expected to Rise in 2024

(November 20, 2023): Medicare, Medicaid, and most private insurance plans cover hospice care and related services. To be eligible for hospice care,[1] a patient must be certified as terminally ill and have a life expectancy of six months or less.  In recent years, the hospice industry has exponentially grown, and the number of Federal, State

Hospice Audit and Investigative Actions are Expected to Rise in 2024 Read More »